Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

bioMérieux S.A.. (4/20/16). "Press Release: bioMérieux – First-quarter 2016 Business Review. Solid Growth in Sales, up 11.5% at Constant Exchange Rates and Scope of Consolidation".

Organisations Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
  Organisation 2 Biotheranostics Inc.
Product Product  FilmArray® PCR test (product series)
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> €489 million in sales

> Up 9.1% as reported

> Americas (up 22.5%) confirms its role as a key growth driver for the Group

> Clinical microbiology: up 6.7%, driven primarily by successful sales of the VITEK® and BacT/ALERT® lines

> FilmArray® Torch high-throughput system CE marked and FDA cleared with all four existing FilmArray® panels

Alexandre Mérieux, Chief Executive Officer, said: "Supported by strong momentum in the Americas and a good start in the Asia-Pacific region, we achieved organic growth of 11.5% in the first three months of the year. Backed by our solid first-quarter 2016 performance, we are continuing our drive to enhance operating efficiency in line with our strategic roadmap and our full-year objectives."

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016.


Consolidated sales rose to €489 million in the first three months of 2016 from €448 million in the year-earlier period. This represents growth of 9.1% as reported and includes a negative currency impact of around €7 million as well as the previously announced deconsolidation of bioTheranostics as of January 1, 2016. Organic growth (at constant exchange rates and scope of consolidation) represented 11.5% year-on-year, led by strong FilmArray® sales (for around 400 basis points), despite a weaker flu season that also began later than in the same period of 2015.

- See more at:

Record changed: 2016-06-01


Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Mérieux (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top